Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 3111, Suchdauer: 0.91s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

von Raab, Marc S. ; Weinhold, Niels ; Kortüm, K. Martin ; et al.

Nature Medicine. :1-9
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

2
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

von Raab, Marc S. ; Weinhold, Niels ; Kortüm, K. Martin ; et al.

Nature Medicine. :1-1
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

3
Temporal genomic dynamics shape clinical trajectory in multiple myeloma

von Maura, Francesco ; Kaddoura, Marcella ; Poos, Alexandra M. ; et al.

Nature Genetics. :1-12
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

4
P58 | TRIAL IN PROGRESS: QUINTESSENTIAL-2 – A PHASE 3 STUDY OF ARLOCABTAGENE AUTOLEUCEL VS. STANDARD OF CARE IN ADULT PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA EXPOSED TO LENALIDOMIDE

von E. Lebel ; A. Abdulgawad ; S. Bramanti ; et al.

Haematologica, Vol 111, Iss s2 (2026)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

5
P42 | COMPARATIVE EFFECTIVENESS OF TECLISTAMAB IN REALITEC VS. REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN LOCOMMOTION AND MOMMENT IN TRIPLE-CLASS EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA

von A. Perrot ; M. Kortüm ; R. Popat ; et al.

Haematologica, Vol 111, Iss s2 (2026)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

6
Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE

von Bahlis, Nizar ; Facon, Thierry ; San-Miguel, Jesus ; et al.

In Blood Advances 14 July 2026 10(13):4541-4550
- View full text via DOI
Merkliste

7
P36 | EFFECTIVENESS OF BRIDGING THERAPY CORRESPONDS TO IMPROVED OUTCOMES AFTER CILTACABTAGENE AUTOLEUCEL: PHASE 3 CARTITUDE-4 STUDY OF PATIENTS WITH RELAPSED, LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA

von E. Zamagni ; B. Dhakal ; S. Iida ; et al.

Haematologica, Vol 111, Iss s2 (2026)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

8
Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement

von Steinhardt, Maximilian J. ; Schaefers, Christoph ; Leypoldt, Lisa B. ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

9
Internet-based indicated prevention of anxiety and depression disorder onset three-arm randomized clinical trial

von Zarski, Anna-Carlotta ; Weisel, Kiona K. ; Berger, Thomas ; et al.

npj Digital Medicine. 8(1)
- Zum Volltext in PubMed Central
Merkliste

10
Correction: Activity of CAR-T cells and bispecific antibodies in multiple myeloma with extramedullary involvement

von Steinhardt, Maximilian J. ; Schaefers, Christoph ; Leypoldt, Lisa B. ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

11
Exploring effects of platelet contractility on the kinetics, thermodynamics, and mechanisms of fibrin clot contraction

von Kliuchnikov, Evgenii ; Peshkova, Alina D. ; Vo, Minh Quan ; et al.

npj Biological Physics and Mechanics. 2(1)
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12
Prospective systematic classification of causes of death in the course of multiple myeloma

von Jin, Jia xiang ; Besemer, Britta ; Yilmaz, Büsranur ; et al.

Blood Cancer Journal. 15(1)
- Zum Volltext in PubMed Central
Merkliste

13
P60 | TRIAL IN PROGRESS, MoMMent-3: A PROSPECTIVE, MULTINATIONAL, REAL-WORLD STUDY OF TALQUETAMAB IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

von K. Weisel ; E. Kastritis ; E. Gonzalez-Garcia ; et al.

Haematologica, Vol 111, Iss s2 (2026)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

14
Efficacy of standalone smartphone apps for mental health: an updated systematic review and meta-analysis

von Kulke, Jennifer K ; Fuhrmann, Lukas M ; Berking, Matthias ; et al.

In The Lancet Digital Health November 2025 7(11)
- View full text via DOI
Merkliste

15
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes

von Facon, Thierry ; Moreau, Philippe ; Weisel, Katja ; et al.

Leukemia. 39(4):942-950
- Zum Volltext (via ReDI)
Merkliste

16
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study

von Moreau, Philippe ; Facon, Thierry ; Usmani, Saad Z. ; et al.

Leukemia. 39(3):710-719
- Zum Volltext (via ReDI)
Merkliste

17
C004 | REALITEC: A MULTI-COUNTRY OBSERVATIONAL RETROSPECTIVE STUDY OF TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OUTSIDE OF CLINICAL TRIALS

von C. Liberatore ; M.C. Da Vià ; K.M. Kortüm ; et al.

Haematologica, Vol 110, Iss s1 (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- Zum Volltext in DOAJ
Merkliste

18
C062 | FIRST RESULTS FROM REALITAL: A EUROPEAN MULTICOUNTRY OBSERVATIONAL RETROSPECTIVE STUDY OF TALQUETAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA OUTSIDE OF CLINICAL TRIALS

von M.C. Da Vià ; K.M. Kortüm ; R. Popat ; et al.

Haematologica, Vol 110, Iss s1 (2025)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- Zum Volltext in DOAJ
Merkliste

19
Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage

von Peshkova, Alina D. ; Rednikova, Ekaterina K. ; Khismatullin, Rafael R. ; et al.

In Blood Advances March 2025
- View full text via DOI
Merkliste

20
Dieses Ergebnis aus wiso kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- View record at wiso
Merkliste

21
Rupture mechanics of blood clots: Influence of fibrin network structure on the rupture resistance

von Ramanujam, Ranjini K. ; Maksudov, Farkhad ; Risman, Rebecca A. ; et al.

In Acta Biomaterialia December 2024 190:329-343
- View full text via DOI
Merkliste

22
Validation of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in patients with multiple myeloma who were enrolled in the CARTITUDE-4 trial

von Mina, Roberto ; Mylin, Anne K. ; Yokoyama, Hisayuki ; et al.

Journal of Patient-Reported Outcomes. 10(1)
- Zum Volltext in PubMed Central
Merkliste

23
T cell redirection as a new standard of care for relapsed multiple myeloma: impact on inpatient capacity, financial burden and infrastructural requirements in Germany

von Ahmadi, P. ; Alsdorf, W. ; Leypoldt, L. ; et al.

Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 60(4):538-540
- Zum Volltext (via ReDI)
Merkliste

24
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

25
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

von Rodriguez-Otero, Paula ; Usmani, Saad ; Cohen, Adam D ; et al.

In The Lancet Oncology May 2024 25(5):e205-e216
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag